Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib
Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added to the study record history, replacing the previous 'Revision: v3.5.3'.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedA minor interface/version update is reflected by changing the displayed “Revision” from v3.5.2 to v3.5.3, without altering the study record content.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the history.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision (v3.5.0) was added to the record history and an older revision (v3.4.3) was removed.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded Revision: v3.4.3 to the record history and removed Revision: v3.4.2.SummaryDifference0.1%

- Check114 days agoChange DetectedA new version entry v3.4.2 was added to the record history, and the previous entry v3.4.1 was removed.SummaryDifference0.1%

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib
Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.